ONYX
Report
- Report Number
- 2029214-2016-00781
- Event Type
- Injury
- Date Received
- September 6, 2016
- Report Date
- August 10, 2016
- Manufacturer
- COVIDIEN (IRVINE)
- Product Code
- MFE
- PMA / PMN Number
- P030004
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CH
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
THE ONYX MODEL AND LOT NUMBER WERE NOT PROVIDED. THERE IS LIMITED INFORMATION ABOUT THE DEVICE AND/OR THE PATIENT. ATTEMPTS WERE MADE TO OBTAIN ADDITIONAL INFORMATION, HOWEVER NO RESPONSE HAS BEEN RECEIVED. THE ONYX WILL NOT BE RETURNED FOR ANALYSIS; THEREFORE, THE EVENT CAUSE COULD NOT BE DETERMINED. MDR 2 OF 3 FROM THE LITERATURE REVIEW OF INCOMPLETE ONYX EMBOLIZATION RESULTING IN GAMMA KNIFE TREATMENT. CITATION: J LIU, X LI, ET AL. TRANSARTERIAL ONYX EMBOLIZATION OF INTRACRANIAL DURAL ARTERIOVENOUS FISTULAS IN ADULTS 21.MARCH.2016, (B)(6) NEUROSURGERY, JTN.
PLEASE REFERENCE MDRS 2029214-2016-00779 AND 2029214-2016-00782 FOR THE OTHER 2 MDRS ASSOCIATED WITH THIS LITERATURE REVIEW.
IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
MEDTRONIC RECEIVED INFORMATION FROM A LITERATURE REVIEW THAT 3 PATIENTS REQUIRED GAMMA KNIFE RADIOSURGERY DUE TO INCOMPLETE EMBOLIZATION WITH THE ONYX. THE SECOND SUBJECT WAS A (B)(6) MALE THAT PRESENTED WITH TRIGEMINAL NEURALGIA. TREATMENT OF THE DURAL ARTERIOVENOUS FISTULA (DAVF) LOCATED IN THE MECKEL CAVE WITH THE ONYX EMBOLIZATION WAS INCOMPLETE, AS INDICATED IN THE POST-TREATMENT ANGIOGRAM, WHICH SHOWED EVIDENCE OF REMNANT FISTULA. AS A RESULT, THE PATIENT UNDERWENT GAMMA KNIFE RADIOSURGERY. FOLLOW UP GLASGOW OUTCOME SCALE (GOS) OF THE PATIENT IS 5 (RESUMPTION OF NORMAL LIFE DESPITE MINOR DEFICITS). CITATION: J LIU, X LI, ET AL. TRANSARTERIAL ONYX EMBOLIZATION OF INTRACRANIAL DURAL ARTERIOVENOUS FISTULAS IN ADULTS 21.MARCH.2016, JOURNAL OF (B)(6) NEUROSURGERY.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 581677 | ONYX | AGENT, INJECTABLE, EMBOLIC | MFE | COVIDIEN (IRVINE) | UNK-NV-ONYX | UNK |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 61 YR | Required Intervention |